← Leaderboards
Andrea Ghetti
Anabios Corporation
$3,749,821
Attributed
$3,749,821
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2014–21$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$3,749,821 · 4
By mechanism
R44$3,229,116 · 2
R43$520,705 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchIn VitroBasePharmaceutical PreparationsPre-ClinicalSafetyTechnologyAction PotentialsMeetingsMeasurementCardiovascular SystemDrug DiscoveryCellsPropertyCommercializationEvaluationCardiacDrug DevelopmentExhibitsAnimal ModelBiological MarkersKidneyNovel TherapeuticsValidation
Grant awards (5)
Development of a novel analgesic for mixed inflammatory and neuropathic pain states$1,734,409
R44 · FY2021 · NS · contact PI
Development of a novel translational pain-drug screening platform for the generation of human-relevant data in preclinical pain drug discovery$320,054
R43 · FY2020 · DA · contact PI
Validation and qualification of an ex vivo human cardiac tissue-based assay for the assessment of the potential cardiotoxicity of pharmaceutical compounds$549,693
R44 · FY2017 · TR · contact PI
Validation and qualification of an ex vivo human cardiac tissue-based assay for the assessment of the potential cardiotoxicity of pharmaceutical compounds$945,014
R44 · FY2016 · TR · contact PI
Validation and qualification of an ex vivo human cardiac tissue-based assay for t$200,651
R43 · FY2014 · TR · contact PI